Panhematin ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
254	ポルフィリン症	2

254. ポルフィリン症

---

臨床試験数 : 70 /  薬物数 : 54 - (DrugBank : 19) / 標的遺伝子数 : 19 - 標的パスウェイ数 : 35

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02922413 (ClinicalTrials.gov)	October 30, 2015	1/1/2016	Panhematin for Prevention of Acute Attacks of Porphyria	Safety and Efficacy of Panhematin™ for Prevention of Acute Attacks of Porphyria	Acute Intermittent Porphyria;Hereditary Coproporphyria;Variegate Porphyria	Biological: Hemin for injection;Other: Placebo	The University of Texas Medical Branch, Galveston	NULL	Recruiting	18 Years	N/A	All	20	Phase 2	United States
2	NCT02180412 (ClinicalTrials.gov)	April 28, 2014	25/6/2014	Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria	A Double-blind, Randomized, Placebo-controlled, Parallel Group Trial on the Efficacy and Safety of PanhematinTM in the Treatment of Acute Attacks of Porphyria	Acute Porphyrias	Biological: Panhematin;Other: Glucose	The University of Texas Medical Branch, Galveston	NULL	Active, not recruiting	18 Years	100 Years	All	40	Phase 2	United States